feed,title,long_url,short_url
Benzinga,"FDA Staff Raises Issues For Sarepta's Duchenne Gene Therapy Data, Analyst Says Issues Known, Expects Positive Vote",https://benzinga.com/general/biotech/23/05/32324172/fda-staff-raises-issues-for-sareptas-duchenne-gene-therapy-data-analyst-says-issues-known-expects,https://da.gd/CVEk
Benzinga,Here's How Much You Would Have Made Owning Parker Hannifin Stock In The Last 15 Years,https://benzinga.com/news/earnings/23/05/32324726/heres-how-much-you-would-have-made-owning-parker-hannifin-stock-in-the-last-15-years,https://da.gd/ZypcL
